Medical Condition News

RSS

Positive new data from Genzyme’s eliglustat tartrate Phase 3 studies on Gaucher disease type 1

Genzyme, a Sanofi company, today announced positive new data from the Phase 3 ENGAGE and ENCORE studies of eliglustat tartrate, its investigational oral therapy for Gaucher disease type 1.

15 Feb 2013

Gedunin could help kill cancer cells

Scientists at the Georgia Regents University Cancer Center have identified an Indian plant, used for centuries to treat inflammation, fever and malaria, that could help kill cancer cells.

15 Feb 2013

Study discovers new predictor for suicidal thinking

When people lose hope that they will ever get another good night's sleep, they become at high risk for suicide, researchers report.

15 Feb 2013

New insights into how cells stick to each other and to other bodily structures

Research carried out by scientists at the Georgia Institute of Technology and The University of Manchester has revealed new insights into how cells stick to each other and to other bodily structures, an essential function in the formation of tissue structures and organs. It's thought that abnormalities in their ability to do so play an important role in a broad range of disorders, including cardiovascular disease and cancer.

15 Feb 2013

Negative obesity stories could discourage men in African-American community from taking action

Obesity rates have increased dramatically in the last few decades. According to the U.S. Census Bureau, African Americans make up more than 60 percent of the overweight and obese population, while only 13 percent of the total population.

15 Feb 2013

U.S. Marshals seize tainted dietary supplements from Globe All Wellness

U.S. Marshals, acting on behalf of the U.S. Food and Drug Administration, today seized tainted dietary supplements from Globe All Wellness, LLC (Globe All), in Hollywood, Fla. The products may be unsafe because they contain an undisclosed active pharmaceutical ingredient.

15 Feb 2013

BioAlliance Pharma to extend Validive phase II trial in head and neck cancer

BioAlliance Pharma SA, an innovative Company dedicated to the development of orphan oncology products and to supportive care products, announces the extension of its phase II clinical trial with Validive in the United States in radio/chemotherapy-induced oral mucositis prevention in patients with head and neck cancer.

15 Feb 2013

Protein-restricted diet supplemented with IGF-I may protect from Alzheimer's

Mice with many of the pathologies of Alzheimer's Disease showed fewer signs of the disease when given a protein-restricted diet supplemented with specific amino acids every other week for four months.

15 Feb 2013

Researchers identify new molecular pathway involved in alveoli growth

In a study of mice, researchers at Johns Hopkins have identified a new molecular pathway involved in the growth of tiny air sacs called alveoli that are crucial for breathing. The scientists say their experiments may lead to the first successful treatments to regrow the air sacs in people who suffer from diseases such as emphysema in which the air sacs have been destroyed by years of smoking.

15 Feb 2013

Patient-specific cancer cell lines designed to predict chemotherapy sensitivity

In laboratory studies, scientists at the Johns Hopkins Kimmel Cancer Center have developed a way to personalize chemotherapy drug selection for cancer patients by using cell lines created from their own tumors.

15 Feb 2013

Pairing Avastin with dasatinib can stop lethal spread of glioblastoma multiforme

The drug bevacizumab, also known by the trade name Avastin, shrinks tumors briefly in patients with an aggressive brain cancer known as glioblastoma multiforme, but then they often grow again and spread throughout the brain for reasons no one previously has understood. Now, Mayo Clinic researchers have found out why this happens.

15 Feb 2013

Researchers show how gene mutations shift and evolve over time in chronic lymphocytic leukemia

Tumors are not factories for the mass production of identical cancer cells, but are, in reality, patchworks of cells with different patterns of gene mutations. In a new study, researchers at Dana-Farber Cancer Institute and the Broad Institute show, more fully than ever before, how these mutations shift and evolve over time in chronic lymphocytic leukemia (CLL) - providing a strobe-like look at the genetic past, present, and future of CLL tumors.

15 Feb 2013

Dompé initiates enrollment in rhNGF phase I/II REPARO study for neurotrophic keratitis

The first patient has been enrolled in the phase I/II REPARO study, the first international clinical trial evaluating the ophthalmological use of a topical solution of recombinant human Nerve Growth Factor (rhNGF) for the treatment of moderate to severe neurotrophic keratitis (NK).

15 Feb 2013

Physical activity may reduce risk of depression in patients undergoing bariatric surgery

Adults undergoing bariatric surgery who are more physically active are less likely to have depressive symptoms and to have recently received medication or counseling for depression or anxiety than their less active counterparts, according to new research led by the University of Pittsburgh Graduate School of Public Health.

15 Feb 2013

People with resilient personality profile more likely to have greater energy levels

People with a more resilient personality profile are more likely to have greater energy levels. That's one of the conclusions from a four-year research project led by Antonio Terracciano, associate professor of geriatrics at the Florida State University College of Medicine. His findings are outlined in "Personality, Metabolic Rate and Aerobic Capacity," published in PLOS ONE, a peer-reviewed, open access journal.

15 Feb 2013

FDA committee recommends approval of Guerbet’s Dotarem NDA for adults and children

Guerbet, the contrast agent specialist for medical imaging, today announced that the Medical Imaging Drugs Advisory Committee to US Food and Drug Administration (FDA) has voted unanimously by votes of 17 to 0 to recommend that FDA approve the New Drug Application (NDA) for Dotarem (gadoterate meglumine) for adults, and for pediatric use for children two years of age and older.

15 Feb 2013

Marshfield Clinic’s Heart Health Mobile app wins HSS competition

Marshfield Clinic Research Foundation, a division of Marshfield Clinic, announced today that its first completed mobile app has won a national competition that challenged competitors to develop a program that will help improve heart health in the U.S.

15 Feb 2013

SANA releases new video on Benefits of Soyfoods for Active Adults

The Soyfoods Association of North America today announced that it has released a video on the Benefits of Soyfoods for Active Adults demonstrating how soyfoods can help you stay fit and healthy. Americans who are trying to lead healthier lives will find that soyfoods boost their energy, improve heart health, and provide antioxidants.

15 Feb 2013

Aspen Dental to inaugurate new office in Gallatin, TN on Feb. 21

Aspen Dental is proud to announce that a new Aspen Dental office is opening in Gallatin, TN on Thursday, Feb. 21. Located at 1007 Nashville Pike, the practice will provide dental services that range from dentures and preventive care to general dentistry and restoration.

15 Feb 2013

Third Rock Ventures announces formation of Jounce Therapeutics

Third Rock Ventures, LLC today announced the formation of Jounce Therapeutics, Inc. with a $47 million Series A financing of the company. Jounce is focused on the discovery and development of first-in-class cancer immunotherapies designed to harness the patient's immune system to seek out and attack cancerous cells and tumors.

15 Feb 2013

Medical Condition News

Positive new data from Genzyme’s eliglustat tartrate Phase 3 studies on Gaucher disease type 1

Gedunin could help kill cancer cells

Study discovers new predictor for suicidal thinking

New insights into how cells stick to each other and to other bodily structures

Negative obesity stories could discourage men in African-American community from taking action

U.S. Marshals seize tainted dietary supplements from Globe All Wellness

BioAlliance Pharma to extend Validive phase II trial in head and neck cancer

Protein-restricted diet supplemented with IGF-I may protect from Alzheimer's

Researchers identify new molecular pathway involved in alveoli growth

Patient-specific cancer cell lines designed to predict chemotherapy sensitivity

Pairing Avastin with dasatinib can stop lethal spread of glioblastoma multiforme

Researchers show how gene mutations shift and evolve over time in chronic lymphocytic leukemia

Dompé initiates enrollment in rhNGF phase I/II REPARO study for neurotrophic keratitis

Physical activity may reduce risk of depression in patients undergoing bariatric surgery

People with resilient personality profile more likely to have greater energy levels

FDA committee recommends approval of Guerbet’s Dotarem NDA for adults and children

Marshfield Clinic’s Heart Health Mobile app wins HSS competition

SANA releases new video on Benefits of Soyfoods for Active Adults

Aspen Dental to inaugurate new office in Gallatin, TN on Feb. 21

Third Rock Ventures announces formation of Jounce Therapeutics

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News